There are currently 21 active clinical trials seeking participants for Pulmonary Embolism research studies. The states with the highest number of trials for Pulmonary Embolism participants are Ontario, California, Florida and Pennsylvania.
Endovascular Engineering ENGULF Study
NCT05597891
Recruiting
Evaluation of initial safety and clinical feasibility of the Viper Catheter System for thrombectomy in acute submassive pulmonary embolism (PE).
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
01/18/2024
Locations: Piedmont Heart, Atlanta, Georgia
Conditions: Pulmonary Embolism
Register for Updates
Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever
NCT05273762
Recruiting
This study is focused on investigating the efficacy and safety of the FlowTriever device to treat low-risk submassive pulmonary embolism.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/22/2023
Locations: Northern Westchester Hospital, Mount Kisco, New York +1 locations
Conditions: Pulmonary Embolism
Register for Updates
PET Fibrin Imaging of DVT and PE
NCT04022915
Recruiting
This study aims to investigate a novel positron emission tomography(PET)-probe for imaging of fresh intravascular blood clots in pulmonary embolism (PE) and deep venous thrombosis (DVT).
Gender:
All
Ages:
18 years and above
Trial Updated:
12/05/2023
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism
Register for Updates
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
NCT05050617
Recruiting
This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE. The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/04/2023
Locations: Wellspan York Hospital, York, Pennsylvania
Conditions: Pulmonary Embolism
Register for Updates
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
NCT02810704
Recruiting
PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.
Gender:
All
Ages:
21 years and above
Trial Updated:
10/30/2023
Locations: Mayo Clinic, Scottsdale, Arizona +31 locations
Conditions: Pulmonary Embolism, Venous Thrombosis
Register for Updates
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
NCT05891886
Recruiting
A study of how supplemental oxygen helps patients with acute pulmonary embolism (PE). Hypothesis: Oxygen affects right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (PE) primarily by relieving hypoxic pulmonary vasoconstriction and reducing pulmonary pressure (PA) pressure, and that this process is metabolically driven.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/17/2023
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Pulmonary Embolism, Venous Thromboembolism, Metabolomics, Oxygen Inhalation Therapy
Register for Updates
Implementing Prescriber-Pharmacist Collaborative Care for Evidence-based Anticoagulant Use
NCT05351749
Recruiting
The researchers hypothesize that existing-prescription notifications directed to pharmacists are more likely to lead to a prescription change than existing-prescription notifications directed to prescribers. Furthermore, the researchers hypothesize that the availability of a pharmacist referral option is associated with a higher rate of prescription changes for initial-prescription alerts that are directed to the prescriber at the time of initial-prescribing errors. Findings from this project w... Read More
Gender:
All
Ages:
All
Trial Updated:
09/05/2023
Locations: University of Michigan, Ann Arbor, Michigan
Conditions: Pulmonary Embolism, Venous Thromboembolism, Atrial Fibrillation
Register for Updates
Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
NCT05408546
Recruiting
Phase II trial of TS23
Gender:
All
Ages:
18 years and above
Trial Updated:
07/08/2023
Locations: Cedars Sinai Medical Center, Los Angeles, California
Conditions: Pulmonary Embolism
Register for Updates
Ventilation and Perfusion Scan in Pulmonary Embolism Following Catheter Directed Thrombectomy Versus Anticoagulation Alone
NCT05133713
Recruiting
Clinical presentation of acute pulmonary embolism (PE) is complex and varied and not uncommonly involves respiratory failure with dyspnea or hypoxia. Patients with persisting signs of respiratory failure despite anticoagulation, may benefit from catheter directed thrombectomy. Additionally, patient who receive thrombectomy are likely to have a lower residual thrombus burden measurable by ventilation-perfusion (V/Q) scan, and thereby less likely to develop chronic sequela, including chronic throm... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/21/2022
Locations: Banner University Medical Center, Tucson, Arizona
Conditions: Pulmonary Embolism, Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension
Register for Updates